Research Article
The Combination of CD147 and MMP-9 Serum Levels Is Identified as Novel Chemotherapy Response Markers of Advanced Non-Small-Cell Lung Cancer
Table 2
The comparison of serum CD147 and MMP-9 levels alone and combined with response to chemotherapy in patients with advanced NSCLC.
| Parameter | The first cycle post-chemo | Total | The second cycle post-chemo | Total | The fourth cycle post-chemo | Total | PD | Non-PD | PD | Non-PD | PD | Non-PD |
| CD147 | | | | | | | | | | Positive | 4 | 24 | 28 | 9 | 14 | 23 | 14 | 8 | 22 | Negative | 2 | 23 | 25 | 4 | 23 | 27 | 11 | 6 | 17 | Total | 6 | 47 | 53 | 13 | 37 | 50 | 25 | 14 | 39 | MMP-9 | | | | | | | | | | Positive | 6 | 15 | 21 | 10 | 27 | 37 | 21 | 9 | 30 | Negative | 0 | 32 | 32 | 3 | 10 | 13 | 4 | 5 | 9 | Total | 6 | 47 | 53 | 13 | 37 | 50 | 25 | 14 | 39 | CD147+MMP-9 | | | | | | | | | | Positive | 4 | 10 | 14 | 6 | 4 | 10 | 10 | 5 | 15 | Negative | 2 | 37 | 39 | 7 | 33 | 40 | 15 | 9 | 24 | Total | 6 | 47 | 53 | 13 | 37 | 50 | 25 | 14 | 39 |
|
|